Jonathan Kay

Jonathan Kay Jonathan Hillel Kay (born 1968) is a Canadian journalist. He was the editor-in-chief of ''The Walrus'' (2014–2017), and is a senior editor of ''Quillette''. He was previously comment pages editor, columnist, and blogger for the Toronto-based Canadian daily newspaper ''National Post'', and continues to contribute to the newspaper on a freelance basis. He is also a book author and editor, a public speaker, and a regular contributor to ''Commentary'' and the ''New York Post''. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'Jonathan Kay', query time: 0.05s Refine Results
  1. 1
    Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?

    Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion? by Anne M. Sydor, Emily Bergin, Jonathan Kay, Erik Stone, Robert Popovian

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis

    Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis by Jonathan Kay, Muhammad Rehman, Noriko Iikuni, Daniel F Alvarez, Amy E Bock, Wuyan Zhang

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data

    Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data by Jonathan Kay, Kate L Lapane, Divya Shridharmurthy, Jonggyu Baek, Anthony Nunes, Shao-Hsien Liu

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Development and test-retest reliability of a screening tool for axial spondyloarthritis.

    Development and test-retest reliability of a screening tool for axial spondyloarthritis. by Divya Shridharmurthy, Kate L Lapane, Sara Khan, Esther Yi, Jonggyu Baek, Jonathan Kay, Shao-Hsien Liu

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative study

    Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative study by Kate L. Lapane, Sara Khan, Divya Shridharmurthy, Ariel Beccia, Catherine Dubé, Esther Yi, Jonathan Kay, Shao-Hsien Liu

    Published 2020-09-01
    Get full text
    Article
  6. 6
    Patient perspectives on health care provider practices leading to an axial spondyloarthritis diagnosis: an exploratory qualitative research study

    Patient perspectives on health care provider practices leading to an axial spondyloarthritis diagnosis: an exploratory qualitative research study by Kate L. Lapane, Catherine Dubé, Katarina Ferrucci, Sara Khan, Kristine A. Kuhn, Esther Yi, Jonathan Kay, Shao-Hsien Liu

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study.

    Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study. by Kate L Lapane, Divya Shridharmurthy, Sara Khan, Daniel Lindstrom, Ariel Beccia, Esther Yi, Jonathan Kay, Catherine Dube, Shao-Hsien Liu

    Published 2021-01-01
    Get full text
    Article
  8. 8
    Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize

    Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize by Staci M. Dreyer, Donovan Leiva, Marla Magaña, Marie Pott, Jonathan Kay, Alvaro Cruz, Nicole L. Achee, John P. Grieco, Jefferson A. Vaughan

    Published 2019-08-01
    Get full text
    Article
  9. 9
    Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation

    Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation by Renuka Jain, Daniel P O’Hair, Tanvir K Bajwa, Denise Ignatowski, Daniel Harland, Amanda M Kirby, Tracy Hammonds, Suhail Q Allaqaband, Jonathan Kay, Bijoy K Khandheria

    Published 2017-11-01
    Get full text
    Article
  10. 10
    Examining Treatment Decision‐Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey

    Examining Treatment Decision‐Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey by Woojin Joo, Christopher V. Almario, Mariko Ishimori, Yujin Park, Alma Jusufagic, Benjamin Noah, Lianne S. Gensler, R. Swamy Venuturupalli, Jonathan Kay, Michael H. Weisman, Brennan M.R. Spiegel

    Published 2020-07-01
    Get full text
    Article
  11. 11
    Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2

    Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2 by Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Jonathan Kay, Marina Magrey, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Michael F Mørup, Christine de la Loge

    Published 2024-04-01
    Get full text
    Article
  12. 12
    Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

    Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study by Jonathan Kay, Janusz Jaworski, Rafal Wojciechowski, Piotr Wiland, Anna Dudek, Marek Krogulec, Slawomir Jeka, Agnieszka Zielinska, Jakub Trefler, Katarzyna Bartnicka-Maslowska, Magdalena Krajewska-Wlodarczyk, Piotr A. Klimiuk, Sang Joon Lee, Yun Ju Bae, Go Eun Yang, Jae Kyoung Yoo, Daniel E. Furst, Edward Keystone

    Published 2021-02-01
    Get full text
    Article
  13. 13
    Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

    Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects by Kyung‐Sang Yu, In‐Jin Jang, Hyeong‐Seok Lim, Jang Hee Hong, Min‐Gul Kim, Min Kyu Park, Doo‐Yeoun Cho, Min Soo Park, Jae Yong Chung, Jong‐Lyul Ghim, SeungHwan Lee, Seok Kyu Yoon, In Sun Kwon, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Jung Bin Cha, Daniel E. Furst, Edward Keystone, Jonathan Kay

    Published 2021-07-01
    Get full text
    Article
  14. 14
    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates by Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve Hawkins, Jonathan Kay, Adam Butler, Yaobo Xu, Dan J. Woodcock, Sue Merson, Fiona M. Frame, Atef Sahli, Federico Abascal, CRUK-ICGC Prostate Cancer Group, Iñigo Martincorena, G. Steven Bova, Christopher S. Foster, Peter Campbell, Norman J. Maitland, David E. Neal, Charlie E. Massie, Andy G. Lynch, Rosalind A. Eeles, Colin S. Cooper, David C. Wedge, Daniel S. Brewer

    Published 2022-09-01
    Get full text
    Article

Search Tools: